-
Publication Venue For
-
Changes in survival over time for primary brain and other CNS tumors in the United States, 2004-2017..
160:209-219.
2022
-
Stereotactic Laser Ablation (SLA) followed by consolidation stereotactic radiosurgery (cSRS) as treatment for brain metastasis that recurred locally after initial radiosurgery (BMRS): a multi-institutional experience..
156:295-306.
2022
-
Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US..
152:603-615.
2021
-
A review of glioblastoma immunotherapy..
151:41-53.
2021
-
Immune suppression in gliomas..
151:3-12.
2021
-
Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor..
151:55-62.
2021
-
Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series..
147:477-483.
2020
-
Role of monoamine-oxidase-A-gene variation in the development of glioblastoma in males: a case control study..
145:287-294.
2019
-
Phase II study of Dovitinib in recurrent glioblastoma..
144:359-368.
2019
-
Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT..
144:53-63.
2019
-
Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015..
143:251-260.
2019
-
Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk..
142:479-487.
2019
-
The epidemiology of central and extraventricular neurocytoma in the United States between 2006 and 2014..
143:123-127.
2019
-
Primary brain and other central nervous system tumors in Appalachia: regional differences in incidence, mortality, and survival..
142:27-38.
2019
-
Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?.
140:623-628.
2018
-
Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E status..
140:261-268.
2018
-
Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study..
140:341-349.
2018
-
The clinical importance of medulloblastoma extent of resection: a systematic review..
139:523-539.
2018
-
First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800..
139:135-143.
2018
-
Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models..
138:489-498.
2018
-
Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma..
137:303-311.
2018
-
Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study..
137:409-415.
2018
-
Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas..
137:349-356.
2018
-
Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status..
135:611.
2017
-
Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status..
135:601-609.
2017
-
Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013..
135:433-441.
2017
-
Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma..
135:237-244.
2017
-
A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population..
134:363-369.
2017
-
Do race and age vary in non-malignant central nervous system tumor incidences in the United States?.
134:269-277.
2017
-
GBM radiosensitizers: dead in the water…or just the beginning?.
134:513-521.
2017
-
Management of GBM: a problem of local recurrence..
134:487-493.
2017
-
Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study..
134:55-64.
2017
-
Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system..
133:409-417.
2017
-
Is mortality due to primary malignant brain and other central nervous system tumors decreasing?.
133:265-275.
2017
-
Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report..
133:17-25.
2017
-
Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data..
133:27-35.
2017
-
Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study..
132:55-62.
2017
-
The clinical and financial impact of a pediatric surgical neuro-oncology clinical trial..
132:83-87.
2017
-
Microsurgical resection of vestibular schwannomas: complication avoidance..
130:367-375.
2016
-
Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying)..
130:31-42.
2016
-
Conditional survival after diagnosis with malignant brain and central nervous system tumor in the United States, 1995-2012..
128:419-429.
2016
-
Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial..
128:163-171.
2016
-
Genetic variations in the homologous recombination repair pathway genes modify risk of glioma..
126:11-17.
2016
-
Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma..
126:243-251.
2016
-
Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma..
125:65-74.
2015
-
Incidence of vestibular schwannomas in the United States..
124:223-228.
2015
-
Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better..
124:215-221.
2015
-
Peptide vaccines for the treatment of glioblastoma..
123:433-440.
2015
-
BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial..
123:259-266.
2015
-
Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004-2011..
123:43-51.
2015
-
Prognostic marker analysis in pediatric intracranial ependymomas..
122:255-261.
2015
-
Familial gliomas: cases in two pairs of brothers..
121:135-140.
2015
-
Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria)..
120:539-546.
2014
-
Computer-extracted MR imaging features are associated with survival in glioblastoma patients..
120:483-488.
2014
-
Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients..
120:499-506.
2014
-
Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models..
120:473-481.
2014
-
Patterns of care in adult medulloblastoma: results of an international online survey..
120:125-129.
2014
-
Malignant brainstem gliomas in adults: clinicopathological characteristics and prognostic factors..
119:177-185.
2014
-
Combination of anti-VEGF therapy and temozolomide in two experimental human glioma models..
116:59-65.
2014
-
PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression..
116:89-97.
2014
-
Tumor progression and transformation of low-grade glial tumors associated with pregnancy..
116:113-117.
2014
-
Adult primitive neuroectodermal tumors: the prognostic value of supratentorial location..
114:141-148.
2013
-
O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma..
114:135-140.
2013
-
A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study..
113:127-134.
2013
-
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer..
112:467-472.
2013
-
Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model..
111:97-102.
2013
-
Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233..
110:163-177.
2012
-
Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001)..
109:565-571.
2012
-
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series..
109:63-70.
2012
-
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study..
108:491-498.
2012
-
Assessment of intra-observer variability in measurement of high-grade brain tumors..
108:477-483.
2012
-
Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma..
108:499-506.
2012
-
A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression..
107:343-349.
2012
-
Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients..
107:213-221.
2012
-
Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma..
107:155-164.
2012
-
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study..
106:643-649.
2012
-
Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen..
106:601-610.
2012
-
Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma..
106:409-415.
2012
-
A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma..
105:601-606.
2011
-
Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma..
105:621-627.
2011
-
How parents cope with their child's diagnosis and treatment of an embryonal tumor: results of a prospective and longitudinal study..
105:253-259.
2011
-
Possible association between genetic variants in the H2AFX promoter region and risk of adult glioma in a Chinese Han population..
105:211-218.
2011
-
Dural venous sinus thrombosis in anaplastic astrocytoma following concurrent temozolomide and focal brain radiotherapy plus bevacizumab..
104:595-598.
2011
-
Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy..
103:371-379.
2011
-
Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma..
101:57-66.
2011
-
Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study..
101:267-277.
2011
-
Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme..
101:179-188.
2011
-
Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors..
101:257-265.
2011
-
Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapy..
101:155-159.
2011
-
Bevacizumab fails to treat temporal paraganglioma: discussion and case illustration..
98:427-430.
2010
-
Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1..
98:1-7.
2010
-
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma..
96:219-230.
2010
-
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy..
95:393-400.
2009
-
Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients..
95:129-134.
2009
-
Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing..
94:79-85.
2009
-
Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex.
2023
-
Sluggish cognitive tempo in survivors of pediatric brain tumors.
2013
-
Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers.
2010